Clinical Trial Results

Showing: All studies [change]
Condition: Alzheimer's Location: New York 25 trials found
New Search
Filter
Trial Phase
Study Type
Clinical Trial on Agitation in Alzheimer's Dementia
PHASE2INTERVENTIONAL Maitland, Florida +4 more
RECRUITING
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
NAINTERVENTIONAL Delray Beach, Florida +4 more
RECRUITING
Autoimmune Features of Neurodegenerative Disorders
N/AOBSERVATIONAL New York, New York
RECRUITING
Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
PHASE2INTERVENTIONAL New York, New York
RECRUITING
Aβ Dynamics in LLMD
PHASE4INTERVENTIONAL New York, New York +1 more
RECRUITING
Late Onset Alzheimer's Disease
N/AOBSERVATIONAL Washington D.C., District of Columbia +4 more
RECRUITING
Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients
NAINTERVENTIONAL Menands, New York +1 more
RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
PHASE3INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
Dominantly Inherited Alzheimer Network (DIAN)
N/AOBSERVATIONAL Jacksonville, Florida +4 more
RECRUITING
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Innate Immunity Stimulation Via TLR9 in Early AD
PHASE1INTERVENTIONAL New York, New York
RECRUITING
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
PHASE3INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
Triage Survey for Neurology Research Eligibility
N/AOBSERVATIONAL Boston, Massachusetts +2 more
RECRUITING
Evaluating the Efficacy of the Pain Identification and Communication Toolkit
NAINTERVENTIONAL New York, New York
RECRUITING
Early Age-Related Hearing Loss Investigation (EARHLI)
NAINTERVENTIONAL New York, New York
RECRUITING
NYSCF Scientific Discovery Biobank
N/AOBSERVATIONAL New York, New York
RECRUITING
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
PHASE3INTERVENTIONAL Long Beach, California +4 more
RECRUITING
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
NAINTERVENTIONAL Tucson, Arizona +3 more
RECRUITING
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
PHASE2, PHASE3INTERVENTIONAL Murrieta, California +4 more
RECRUITING
Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
PHASE2INTERVENTIONAL New York, New York
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type